AN OBSERVATIONAL STUDY OF PROCALCITONIN LEVELS AMONG TYPE 2 DIABETES MELLITUS PATIENTS WITH INFECTIONS

Dr. S. Manimekalai, Dr. Lakshmi. C.

Abstract


Objective: To ascertain high PCT levels in Type 2 DM patients among respiratory infections, urinary tract infections and diabetic foot ulcers.

Methods: An observational study was done among Type 2 DM patients with three groups namely GRP-1 (respiratory infections), GRP-2 (urinary tract infections) and GRP-3 (diabetic foot ulcer).

Results: Among the three groups it was found that the sensitivity (true positive rate) was 0.93 for GRP-1, 0.96 for GRP-2, 0.95 for GRP-3; specificity (true negative rate) was 0.83 for GRP-1, 0.71 for GRP-2, 0.89 for GRP-3 and accuracy was 0.90 for GRP1 and GRP2, 0.93 for GRP-3.

Conclusion: PCT showed significant correlation with each of the three infections that were taken for study. Further, studies with larger number of samples when done along with other sepsis biomarkers can give more significant diagnostic results.


Keywords


Procalcitonin, bio marker, diabetes mellitus, ELISA, respiratory infection, urinary tract infection, foot ulcer, skin and soft tissue infection.

Full Text:

PDF

References


Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54:e132–73.

Brownrigg JR, Davey J, Holt PJ, Davis WA, Thompson MM, Ray KK, et al. The association of ulceration of the foot with cardiovascular and all-cause mortality in patients with diabetes: A meta-analysis. Diabetologia. 2012;55:2906–12.

Jeandrot A, Richard JL, Combescure C, Jourdan N, Finge S, Rodier M, et al. Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: A pilot study. Diabetologia. 2008;51:347–52.

Jonaidi Jafari N, Safaee Firouzabadi M, Izadi M, Safaee Firouzabadi MS, Saburi A. Can procalcitonin be an accurate diagnostic marker for the classification of diabetic foot ulcers? Int J Endocrinol Metab. 2014;12:e13376.

Christ-Crain M, Müller B. Procalcitonin in bacterial infections – Hype, hope, more or less? Swiss Med Wkly. 2005;135:451–60.

Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341:515–8.

Schmiemann G, Kniehl E, Gebhardt K, Matejczyk MM, Hummers-Pradier E, The diagnosis of urinary tract infection: a systematic review, Dtsch. Arztebl. Int. 2010: 361-367.

Lee H, Procalcitonin as a biomarker of infectious diseases, Korean J. Intern. Med. 2013:28:285-291.

Bharath MS, Hiremath RS, Basu A, Role of procalcitonin and C-reactive protein in urinary tract infection diagnosis in adults, Int. J. Adv. Med. 2017:4:417-419.


Refbacks

  • There are currently no refbacks.